L&S Knock-Out ARRD 12.06.2024/ DE000LX3NJC1 /
23/05/2024 13:15:35 | Diferencia-0.02 | Bid13:15:35 | Ask13:15:35 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
0.58EUR | -3.33% | 0.58 Volumen de oferta: - |
0.59 Tamaño/ Volumen/ Formato de Ask: - |
ARCELORMITTAL S.A. N... | 18.00 EUR | 12/06/2024 | Call |
GlobeNewswire
13:03
Unicycive Therapeutics to Participate in a Fireside Chat at the Lytham Partners Spring 2024 Investor...
GlobeNewswire
13:00
atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors
GlobeNewswire
13:00
OneMedNet Reports Greater than Five-Fold Expansion of iRWD™ Network and Platform
GlobeNewswire
13:00
Sono-Tek Announces Fiscal Year 2024 Results with Record-Breaking Revenue and Record YOY Backlog
GlobeNewswire
13:00
Hydreight Technologies through its associated Medical network now offer Tirzepatide to Product Offer...
GlobeNewswire
13:00
Leading Proxy Advisory Firm ISS Recommends that Mayfair Gold Shareholders Vote FOR All Company Nomin...
GlobeNewswire
13:00
TFF Pharmaceuticals and Leidos to Advance Next-Generation Biodefense Countermeasures Under the DARPA...
GlobeNewswire
13:00
Pyro Green-Gas Signs Contracts Totaling $1.3 Million with Global Steel Company to Desulphurize Coke ...
GlobeNewswire
13:00
Immersive Fishing and Boating Sim ‘Ships at Sea’ from Misc Games Available Now in PC Early Access
GlobeNewswire
13:00
Sandy Spring Bancorp’s Board of Directors Appoints Charles S. Cullum Chief Financial Officer
GlobeNewswire
13:00
Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Pr...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página